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L-Glutamate is a major excitatory neurotransmitter in the mammalian brain. 
Excessive stimulation of excitatory amino acid receptors has been implicated in 
neurodegenerative disorders such as Alzheimers disease (1); hypofunction of the 
glutamate system may be involved in schizophrenic-like disorders (2). Three 
distinct pharmacological classes of glutamate receptors have been identified 
which reflect the actions of the relatively selective agonists kainate, 
quisqualate and N-methyl-D-aspartate (NMDA). Recent findings (3) suggest that 
drugs such as phencyclidine (PCP) and the PCP analog TCP bind either to an 
allosteric NMDA site or possibly t o  the open channel itself. These findings 
have created a renewed interest developing a radiolabeled PCP-like compound 
for mapping NMDA-linked glutamate receptors in the mammalian brain by PET. 
[18F]Labeled analogs of PCP (1) are currently under investigation in our 
laboratories for imaging NMDA-type glutamate receptors in brain. This paper 
presents our preliminary efforts aimed at: 1) determining which position(s) 
fluorine can be incorporated in the PCP molecule without adversely affecting i s 
PCP-like potency; 2) developing rapid synthetic methods for incorporating 18F 
(t% = 110 min) into these compounds for use in in vivo mapping of the glutamate 
receptor complex by PET. We have shown that 3-a&1o-4-fluoroPCP (2) retains the 
high binding affinity and pharmaco ogical potency of 3-aminoPCP (2): IC50-300 
and 200 nM, respectively, in the 4H-TCP competitive binding assay and ED50t4.48 
and 4.55 p/mol/kg, respectively, in the mouse platform test. The synthesis of 
4-[18FJfluoro-3-aminoPCP (6) was achieved by nucleophilic displacement of 
bromide in 4-bromo-3-nitroPCP ( 4 )  by nca [ 18F]fluoride ion, followed by 
reduction of the nitro intermediat ( 5 )  with stannous chloride/HCl. In a 
typi a1 synthesis 22 mCi of [f8F]Tluoride affords 0.60 mCi (EOS) of 
4-[1gF]fluoro-3-aminoPCP in a synthesis time of 115 min. Purification was 
achieved by reverse-phase HPLC. Biological evaluation of this new fluorine-18 
ligand is in progress. 
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Table 1 
Comparison of relative potencies* and affinities** of PCP analogs 
ED50 95% C.L. Relative IC50 Relative 
Analog M.W. (u/mol/kg) (U/mol/kg) Potency nM Affinity 
PCP 243 19.1 12-6-28 9 1 400 1 
e-F-PCP 261 47.5 36.9-61.0 0.4 1200 0.33 
m-NH2-PCP 258 4.55 3.7- 5.7 4.2 200 2 - 
e-F-m-NH2-PCP 276 4.48 3.5- 5.8 4.3 300 1.33 
*In the mouse platform test 
**[3H]TCP receptor binding sites 
